TY - JOUR
T1 - In-hospital stroke after transcatheter aortic valve implantation
T2 - A UK observational cohort analysis
AU - Myat, Aung
AU - Buckner, Luke
AU - Mouy, Florence
AU - Cockburn, James
AU - Baumbach, Andreas
AU - Banning, Adrian P.
AU - Blackman, Daniel J.
AU - Curzen, Nick
AU - MacCarthy, Philip
AU - Mullen, Michael
AU - de Belder, Mark
AU - Cox, Ian
AU - Kovac, Jan
AU - Brecker, Stephen
AU - Turner, Mark
AU - Khogali, Saib
AU - Malik, Iqbal S.
AU - Alsanjari, Osama
AU - Redwood, Simon
AU - Prendergast, Bernard
AU - Trivedi, Uday
AU - Robinson, Derek
AU - Ludman, Peter
AU - de Belder, Adam
AU - Hildick-Smith, David
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Objectives: We sought to identify baseline demographics and procedural factors that might independently predict in-hospital stroke following transcatheter aortic valve implantation (TAVI). Background: Stroke is a recognized, albeit infrequent, complication of TAVI. Established predictors of procedure-related in-hospital stroke; however, remain poorly defined. Methods: We conducted an observational cohort analysis of the multicenter UK TAVI registry. The primary outcome measure was the incidence of in-hospital stroke. Results: A total of 8,652 TAVI procedures were performed from 2007 to 2015. There were 205 in-hospital strokes reported by participating centers equivalent to an overall stroke incidence of 2.4%. Univariate analysis showed that the implantation of balloon-expandable valves caused significantly fewer strokes (balloon-expandable 96/4,613 [2.08%] vs. self-expandable 95/3,272 [2.90%]; p =.020). After multivariable analysis, prior cerebrovascular disease (CVD) (odds ratio [OR] 1.51, 95% confidence interval [CI 1.05–2.17]; p =.03), advanced age at time of operation (OR 1.02 [0.10–1.04]; p =.05), bailout coronary stenting (OR 5.94 [2.03–17.39]; p =.008), and earlier year of procedure (OR 0.93 [0.87–1.00]; p =.04) were associated with an increased in-hospital stroke risk. There was a reduced stroke risk in those who had prior cardiac surgery (OR 0.62 [0.41–0.93]; p =.01) and a first-generation balloon-expandable valve implanted (OR 0.72 [0.53–0.97]; p =.03). In-hospital stroke significantly increased 30-day (OR 5.22 [3.49–7.81]; p <.001) and 1-year mortality (OR 3.21 [2.15–4.78]; p <.001). Conclusions: In-hospital stroke after TAVI is associated with substantially increased early and late mortality. Factors independently associated with in-hospital stroke were previous CVD, advanced age, no prior cardiac surgery, and deployment of a predominantly first-generation self-expandable transcatheter heart valve.
AB - Objectives: We sought to identify baseline demographics and procedural factors that might independently predict in-hospital stroke following transcatheter aortic valve implantation (TAVI). Background: Stroke is a recognized, albeit infrequent, complication of TAVI. Established predictors of procedure-related in-hospital stroke; however, remain poorly defined. Methods: We conducted an observational cohort analysis of the multicenter UK TAVI registry. The primary outcome measure was the incidence of in-hospital stroke. Results: A total of 8,652 TAVI procedures were performed from 2007 to 2015. There were 205 in-hospital strokes reported by participating centers equivalent to an overall stroke incidence of 2.4%. Univariate analysis showed that the implantation of balloon-expandable valves caused significantly fewer strokes (balloon-expandable 96/4,613 [2.08%] vs. self-expandable 95/3,272 [2.90%]; p =.020). After multivariable analysis, prior cerebrovascular disease (CVD) (odds ratio [OR] 1.51, 95% confidence interval [CI 1.05–2.17]; p =.03), advanced age at time of operation (OR 1.02 [0.10–1.04]; p =.05), bailout coronary stenting (OR 5.94 [2.03–17.39]; p =.008), and earlier year of procedure (OR 0.93 [0.87–1.00]; p =.04) were associated with an increased in-hospital stroke risk. There was a reduced stroke risk in those who had prior cardiac surgery (OR 0.62 [0.41–0.93]; p =.01) and a first-generation balloon-expandable valve implanted (OR 0.72 [0.53–0.97]; p =.03). In-hospital stroke significantly increased 30-day (OR 5.22 [3.49–7.81]; p <.001) and 1-year mortality (OR 3.21 [2.15–4.78]; p <.001). Conclusions: In-hospital stroke after TAVI is associated with substantially increased early and late mortality. Factors independently associated with in-hospital stroke were previous CVD, advanced age, no prior cardiac surgery, and deployment of a predominantly first-generation self-expandable transcatheter heart valve.
KW - aortic stenosis
KW - balloon-expandable heart valve
KW - self-expandable heart valve
UR - http://www.scopus.com/inward/record.url?scp=85089258044&partnerID=8YFLogxK
U2 - 10.1002/ccd.29157
DO - 10.1002/ccd.29157
M3 - Article
AN - SCOPUS:85089258044
SN - 1522-1946
JO - CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
JF - CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
ER -